Industry Pipeline - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Industry Pipeline
Interphex Showcase 2010.

Pharmaceutical Technology
Volume 34, Issue 4, pp. 128-135

Manufacturing capabilities
Lyne Laboratories offers its explosion-proof manufacturing capabilities for high-concentration, flammable pharmaceuticals. Lyne's state-of-the-art facility was designed specifically for formulations high in alcohol content and for solvent-based drug products. Batch sizes range from 1000 to 8000 L. Lyne is registered with the US Food and Drug Administration and licensed by the Drug Enforcement Administration. Lyne Laboratories, Brockton, MA tel. 800.525.0450

Contract Services
Chemic Laboratories is a contract facility that follows good manufacturing and laboratory practices. The company offers extractables-leachables analysis, methods development and validations, bioanalytical services, organic synthesis and formulation development, and stability testing. The independent Chemic Consulting Consortium advises clients throughout their product-development cycles. Chemic Laboratories, Canton, MA tel. 781.821.5600

Contract services
Mikart has provided contract development, manufacturing, and packaging services to the pharmaceutical industry since 1975. The company's capabilities include formulation development; analytical services; solid- and liquid-dose manufacturing; packaging in bottles, blisters, and multilaminate pouches; project management; and regulatory services. Mikart, Atlanta, GA tel. 888.4MIKART

Drug-delivery solutions
For more than 50 years, companies have looked to 3M Drug Delivery Systems for solutions to help their products meet the market's needs. 3M offers inhalation and transdermal drug-delivery systems and components, including dry-powder inhaler and microneedle technologies, plus state-of-the-art contract manufacturing services to help ensure technical success. 3M Drug Delivery Systems, St. Paul, MN tel. 800.643.8086


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Pharmaceutical Technology,
Click here